文献速递肾癌与肾肿瘤

浸润性肾肿物的临床意义与记录准确性

Infiltrative Renal Masses: Clinical Significance and Fidelity of Documentation.
PubMed 文献 · Eur Urol Oncol · 2019-08-20

本研究分析了522例接受肾部分或根治性切除术的局部晚期/侵袭性肾肿瘤患者,发现25%存在浸润性特征,但61%的影像报告未记录。浸润性特征、播散性疾病和非肾细胞癌组织学是癌症特异性死亡的独立预测因素。

要点

  • 局部晚期/侵袭性肾肿瘤中25%有浸润性特征,但多数未被记录。
  • 浸润性特征是癌症特异性死亡的独立预测因素(HR 1.73)。
  • 无论是否记录,浸润性特征对预后影响无差异。

核心结论

  • 25%的局部晚期/组织学侵袭性肾肿瘤具有浸润性特征,但许多未被记录为浸润性肾肿物。
  • 浸润性特征是癌症特异性死亡的独立预测因素,无论是否被记录。

研究设计与样本

  • 回顾性分析522例2012-2014年接受肾部分或根治性切除术的肾肿瘤患者,病理为局部晚期和/或侵袭性组织学。
  • 术前CT/MRI由两位放射科医生独立回顾性审阅。

主要发现

  • 中位肿瘤大小6.9cm,肾细胞癌占92%。
  • 影像审阅确认133例(25%)为浸润性肾肿物,其中103例为肾细胞癌;59例有肉瘤样或低分化特征。
  • 浸润性肾肿物更大、更常有症状,且播散性疾病更常见(均p<0.001)。
  • 109例浸润性肾肿物在本中心成像,42例术前影像报告记录为浸润性肾肿物,67例(61%)未记录浸润性特征。
  • 67例未记录者中仅4例(6%)被手术团队记录为浸润性。

关键数值与推荐

  • 多变量分析:浸润性特征、播散性疾病和非肾细胞癌组织学是癌症特异性死亡的独立预测因素(HR [95%CI]分别为1.73 [1.21-2.47]、2.98 [2.10-4.23]、2.79 [1.86-4.62])。
  • 浸润性肾肿物中,广泛浸润性特征和播散性疾病与癌症特异性死亡相关(HR [95%CI]分别为1.98 [1.27-3.07]和2.35 [1.52-3.63]),记录状态无关联。
  • 排除播散性疾病或术后残留癌患者,浸润性肾肿物复发率62% vs 非浸润性22%(p<0.001),记录与未记录浸润性肾肿物间无显著差异(p=0.36)。

临床怎么用

  • 在肾肿物评估中应常规评估并记录浸润性特征。
  • 影像报告和手术记录应明确描述浸润性特征以改善风险分层。

局限性

  • 回顾性设计。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The prevalence of infiltrative renal masses (IRMs) and fidelity of documentation of infiltrative features remain unclear. OBJECTIVE: To investigate the prevalence/significance of IRMs and assess whether infiltrative features were documented preoperatively. DESIGN, SETTING, AND PARTICIPANTS: A total of 522 patients with renal tumors managed with partial/radical nephrectomy (2012-2014) whose pathology demonstrated locally advanced and/or aggressive histology were analyzed. Preoperative computed tomography/magnetic resonance imaging was retrospectively/independently reviewed by two radiologists. IRMs were required to have a poorly defined interface with parenchyma and nonelliptical shape in one or more distinct/unequivocal areas. Infiltrative features were defined as extensive or focal. INTERVENTION: Partial/radical nephrectomy. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: Cancer-specific mortality (CSM) was estimated using cumulative-incidence analysis. Significant and independent predictors of CSM were evaluated using Cox proportional hazard analysis. RESULTS AND LIMITATIONS: Median tumor size was 6.9cm; renal cell carcinomas (RCCs) predominated (92%). Image review confirmed 133 IRMs (25%), including 103 RCCs; 59 had sarcomatoid or poorly differentiated features. IRMs were larger and more often symptomatic compared than non-IRMs, and disseminated disease was also more common for IRMs (all p<0.001). Overall, 109 IRMs were imaged at our center; 42 were documented as IRMs in preoperative radiology reports, while infiltrative features were not documented in 67 (61%). Only four (6%) of these 67 were documented as infiltrative by the surgical team. Infiltrative features were more often focal in undocumented IRMs. On multivariable analysis, infiltrative features, disseminated disease, and non-RCC histology were independent predictors of CSM (hazard ratio or HR [95% confidence interval {CI}]=1.73 [1.21-2.47], 2.98 [2.10-4.23], and 2.79 [1.86-4.62], respectively). Among IRMs, extensive infiltrative features and disseminated disease were associated with CSM (HR [95% CI]=1.98 [1.27-3.07] and 2.35 [1.52-3.63], respectively), while documentation status failed to show an association. Excluding patients with disseminated disease or residual cancer after surgery, recurrence rates were 62% for IRMs versus 22% for non-IRMs (p<0.001), and there was again no significant difference between documented and undocumented IRMs (p=0.36). Limitations include a retrospective design. CONCLUSIONS: Twenty-five percent of locally advanced/histologically aggressive renal tumors exhibited infiltrative features, although many were not documented as IRMs. Among this high-risk surgical population, infiltrative features were independent predictors of CSM, irrespective of whether they were documented or not. Our data suggest that infiltrative features should be assessed and documented routinely during evaluation of renal masses. PATIENT SUMMARY: Infiltrative renal masses may be more common than previously appreciated, although many were not documented as infiltrative during preoperative evaluation. Our data suggest that infiltrative features have a strong impact on prognosis and should be assessed and documented routinely during radiologic and clinical evaluation of renal masses.

来源:Eur Urol Oncol,查看原文。版权归原作者所有。

引用

  1. Tanaka H, Ding X, Ye Y, et al. Infiltrative Renal Masses: Clinical Significance and Fidelity of Documentation. Eur Urol Oncol. 2019. PMID: 31439434. doi:10.1016/j.euo.2019.07.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。